Medicalgorithmics S.A. (MDG.WA)
PLN 25.6
(0.79%)
PLN 25.6
(0.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -578 Thousand PLN | -103.2% |
| 2022 | 18.08 Million PLN | 110.01% |
| 2021 | -180.63 Million PLN | -552.69% |
| 2020 | -27.67 Million PLN | -9156.19% |
| 2019 | -299 Thousand PLN | -102.07% |
| 2018 | 14.41 Million PLN | -43.55% |
| 2017 | 25.53 Million PLN | -36.32% |
| 2016 | 40.1 Million PLN | 188.02% |
| 2015 | 13.92 Million PLN | -4.14% |
| 2014 | 14.52 Million PLN | 33.59% |
| 2013 | 10.87 Million PLN | 46.18% |
| 2012 | 7.43 Million PLN | 147.47% |
| 2011 | 3 Million PLN | 57.38% |
| 2010 | 1.9 Million PLN | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -5.31 Million PLN | -32.7% |
| 2024 Q1 | -4 Million PLN | -492.6% |
| 2023 Q4 | -676 Thousand PLN | -279.78% |
| 2023 Q2 | -1.24 Million PLN | -181.76% |
| 2023 Q1 | 1.51 Million PLN | 61.94% |
| 2023 Q3 | -178 Thousand PLN | 85.67% |
| 2023 FY | -578 Thousand PLN | -103.2% |
| 2022 Q3 | 4.62 Million PLN | -63.07% |
| 2022 Q1 | -55.43 Million PLN | 68.58% |
| 2022 FY | 18.08 Million PLN | 110.01% |
| 2022 Q4 | 938 Thousand PLN | -79.72% |
| 2022 Q2 | 12.52 Million PLN | 122.59% |
| 2021 Q3 | -1.35 Million PLN | 26.74% |
| 2021 Q2 | -1.85 Million PLN | -82.91% |
| 2021 Q1 | -1.01 Million PLN | 79.83% |
| 2021 FY | -180.63 Million PLN | -552.69% |
| 2021 Q4 | -176.42 Million PLN | -12910.32% |
| 2020 FY | -27.67 Million PLN | -9156.19% |
| 2020 Q3 | -3.44 Million PLN | -188.68% |
| 2020 Q1 | -3.26 Million PLN | -95.39% |
| 2020 Q4 | -5.01 Million PLN | -45.7% |
| 2020 Q2 | -1.19 Million PLN | 63.46% |
| 2019 Q3 | 80 Thousand PLN | -94.29% |
| 2019 Q4 | -1.67 Million PLN | -2188.75% |
| 2019 FY | -299 Thousand PLN | -102.07% |
| 2019 Q1 | 4.46 Million PLN | -25.97% |
| 2019 Q2 | 1.4 Million PLN | -68.61% |
| 2018 Q1 | 4.1 Million PLN | -44.19% |
| 2018 FY | 14.41 Million PLN | -43.55% |
| 2018 Q4 | 6.03 Million PLN | 226.69% |
| 2018 Q3 | 1.84 Million PLN | -24.15% |
| 2018 Q2 | 2.43 Million PLN | -40.61% |
| 2017 Q4 | 7.34 Million PLN | -13.11% |
| 2017 Q1 | 1.96 Million PLN | -93.65% |
| 2017 FY | 25.53 Million PLN | -36.32% |
| 2017 Q2 | 7.77 Million PLN | 296.38% |
| 2017 Q3 | 8.45 Million PLN | 8.71% |
| 2016 Q3 | 4.5 Million PLN | -57.9% |
| 2016 FY | 40.1 Million PLN | 188.02% |
| 2016 Q4 | 30.88 Million PLN | 585.61% |
| 2016 Q1 | -5.98 Million PLN | -797.67% |
| 2016 Q2 | 10.7 Million PLN | 278.82% |
| 2015 FY | 13.92 Million PLN | -4.14% |
| 2015 Q1 | 5.06 Million PLN | 81.38% |
| 2015 Q4 | 857.7 Thousand PLN | -68.94% |
| 2015 Q3 | 2.76 Million PLN | -47.3% |
| 2015 Q2 | 5.23 Million PLN | 3.41% |
| 2014 Q1 | 3.77 Million PLN | 26.02% |
| 2014 Q2 | 3.86 Million PLN | 2.41% |
| 2014 Q3 | 4.09 Million PLN | 6.03% |
| 2014 Q4 | 2.79 Million PLN | -31.81% |
| 2014 FY | 14.52 Million PLN | 33.59% |
| 2013 Q3 | 2.82 Million PLN | 7.2% |
| 2013 FY | 10.87 Million PLN | 46.18% |
| 2013 Q2 | 2.63 Million PLN | 5.08% |
| 2013 Q1 | 2.5 Million PLN | 2.42% |
| 2013 Q4 | 2.99 Million PLN | 6.1% |
| 2012 Q4 | 2.44 Million PLN | 20.31% |
| 2012 Q1 | 1.32 Million PLN | 0.0% |
| 2012 FY | 7.43 Million PLN | 147.47% |
| 2012 Q2 | 1.63 Million PLN | 23.6% |
| 2012 Q3 | 2.03 Million PLN | 24.19% |
| 2011 FY | 3 Million PLN | 57.38% |
| 2010 FY | 1.9 Million PLN | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Adiuvo Investments S.A. | -10.84 Million PLN | 94.668% |
| Genomtec S.A. | -9.01 Million PLN | 93.587% |
| Medinice S.A. | -5.07 Million PLN | 88.604% |
| Synektik Spólka Akcyjna | 84.63 Million PLN | 100.683% |